AIP: A proposed mechanism for evaluating adherence improvement initiatives

Advances in Therapy

Volumn 22, Issue 2, 2005, Pages 87-95

  Day, David ^a  

^a PFIZER INC   (United States)

Author keywords

Adherence; AIP; Drugs; Medication; Pharmacy; Prescription

Indexed keywords

ARTICLE; COMPUTER PROGRAM; DATA BASE; DRUG COST; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; HUMAN; LONG TERM CARE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACY; PRESCRIPTION;

EID: 21044432722     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02849880     Document Type: Article

References (22)

1. Taneja N, Wiegmann DA. The role of perception in medication errors: implications for non-technological interventions. MJAFI. 2004;60:172-176.
2. Donovan JL. Patient decision making: the missing ingredient in compliance research. Int J Technol Assess Health Care. 1995;11:443-455.
3. Vermeire E, Heamshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331-342.
4. TenHave TR, Coyne J, Salzer M, Katz I. Research to improve the quality of care for depression: alternatives to the simple randomized clinical trial. Gen Hosp Psychiatry. 2003;25:115-123.
5. Griffith S. A review of the factors associated with patient compliance and the taking of prescribed medicines. Br J Gen Pract. 1990;40:114-116.
6. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085-1090.
7. Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging. 2004;21:793-811.
8. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455-461.
9. Marentette MA, Gerth WC, Billings DK, Zamke KB. Antihypertensive persistence and drug class. Can J Cardiol. 2002;18:649-656.
10. Day D. Use of pharmacy claims databases to determine rates of medication adherence. Adv Ther. 2003;20:164-176.
11. Wogen J, Kreilick CA, Livornese RC, Yokoyama K, Frech F. Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care setting. J Manag Care Pharm. 2003;9:424-429.
12. Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry. 2002;159:103-108.
13. Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol. 1997;79:177-185.
14. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
15. Weilburg JB, O'Leary KM, Meigs JB, Hennen J, Stafford RS. Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv. 2003;54:1233-1239.
16. Gilbody SM, House AO, Sheldon TA. Outcomes research in mental health: systematic review. Br J Psychiatry. 2002;181:8-16.
17. Rand CS. Adherence to asthma therapy in the preschool child. Allergy. 2002;57(suppl 74):48-57.
18. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462-467.
19. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a crossnational study. JAMA. 1998;279:1458-1462.
20. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868-2879.
21. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164:722-732.
22. Vitolins MZ, Rand CS, Rapp SR, Ribisl PM, Sevick MA. Measuring adherence to behavioral and medical interventions. Control Clin Trials. 2000;21(suppl):188S-194S.